Related Experiment Video
Updated: Jan 11, 2026

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
JAK2/JAK2V617F heterodimers activate STAT1 and AhR to promote thrombocytosis
Radek C Skoda1, Olli Silvennoinen2
1Baylor College of Medicine, Dan L. Duncan Comprehensive Cancer Center , Houston, TX, USA.
In this issue of JEM, Zhou et al. (https://doi.org/10.1084/jem.20250153) report that hematopoietic progenitors heterozygous for the JAK2V617F mutation preferentially activate STAT1, promoting platelet production and thrombocythemia, whereas homozygous progenitors activate STAT5, leading to erythrocytosis and polycythemia.
In this issue of JEM, Zhou et al. (https://doi.org/10.1084/jem.20250153) report that hematopoietic progenitors heterozygous for the JAK2V617F mutation preferentially activate STAT1, promoting platelet production and thrombocythemia, whereas homozygous progenitors activate STAT5, leading to erythrocytosis and polycythemia.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Amplifying Signals via Enzymatic Cascade
Receptor Tyrosine Kinases
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades

